参考文献/References:
[1] Hossein-Nezhad A, Mirzaei K, Ansar H, et al. Obesity, inflammation and resting energy expenditure: possible mechanism of progranulin in this pathway[J].Minerva endocrinologica,2012,37(3)：255-266.
[2] 张 璇,魏科祥.化瘀益肾饮对糖尿病早期肾病Hcy及CysC的影响[J].陕西中医,2017,38(2):207-208.
[3] Garcia-Garcia PM, Getino-Melian MA, Dominguez-Pimentel V, et al.Inflammation in diabetic kidney disease[J]. World Journal of Diabetes,2014, 5(4)：431-443.
[4] Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M,et al.Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J].Nature Reviews Nephrology,2011,7(6)：327-340.
[5] He Z, Bateman A.Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo[J]. Cancer Research,1999, 59(13)：3222-3229.
[6] Baker CA, Manuelidis L.Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease[J]. Proceedings of the National Academy of Sciences of the United States of America,2003, 100(2)：675-679.
[7] He Z, Ong CH, Halper J, et al.Progranulin is a mediator of the wound response[J]. Nature Medicine, 2003, 9(2)：225-229.
[8] Lopez de Munain A, Alzualde A, Gorostidi A,et al.Mutations in progranulin gene：clinical, pathological, and ribonucleic acid expression findings[J].Biological Psychiatry,2008,63(10)：946-952.
[9] 陶 疆.颗粒蛋白前体与伤口愈合关系的研究进展[J].医学临床研究,2009,8(26)：1544-1546.
[10] Zhao YP, Tian QY, Frenkel S, et al.The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling[J].Biomaterials,2013,34(27)： 6412-6421.
[11] Nukiwa T, Suzuki T, Fukuhara T, et al.Secretory leukocyte peptidase inhibitor and lung cancer[J]. Cancer Science,2008, 99(5)：849-855.
[12] Kloting N,Fasshauer M,Dietrich A,et al.Insulin-sensitive obesity[J].American Journal of Physiology Endocrinology and Metabolism,2010, 299(3)：506-515.
[13] Matsubara T, Mita A, Minami K, et al.PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue[J]. Cell Metabolism,2012, 15(1):38-50.
[14] Youn BS, Bang SI, Kloting N, et al.Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue[J]. Diabetes,2009, 58(3):627-636.
相似文献/References:
[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(8):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(8):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(8):1032.
[7]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(8):1163.
[8]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[9]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(8):619.
[10]陈伟国,朱萧玲,常 盼,等.2型糖尿病患者冠状动脉狭窄程度危险因素分析*[J].陕西医学杂志,2020,49(6):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]
CHEN Weiguo,ZHU Xiaoling,CHANG Pan,et al.Risk factors of coronary stenosis in patients with type 2 diabetes mellitus[J].,2020,49(8):672.[doi:DOI:10.3969/j.issn.10007377.2020.06.008]